Abstract
The lipid-lowering agents, statins, are the most commonly prescribed class of drugs in the western world. Because of their widespread use, many patients undergo surgical procedures while on statins. Statins, in addition to cholesterol-lowering effects, also have anticoagulant, immunosuppressive, and antiproliferative properties that may affect the risk of local wound complications. This study investigated the relationship between statins and postoperative wound complications in a large cohort of patients undergoing inguinal or ventral hernia repair. Data mining was performed in the Veterans Integrated Service Network (VISN)16 Data Warehouse. This database contains clinical and demographic information about all veterans cared for at the ten VA Medical Centers that comprise the South Central VA Healthcare Network in the mid-south region of the US. Aggregate data (age, body mass index, smoking history, gender, race, history of diabetes, statin use, and postoperative wound complications) were obtained for all patients who underwent inguinal or ventral hernia repair during the period October 1, 1996–November 30, 2004. During the period of the query, 10,782 patients (10,676 male, 106 female), 1,242 (11.5%) of whom received statins, underwent herniorrhaphy. Statin use did not affect the risk of wound infection or delayed wound healing. Statin use was, however, associated with an increased rate of local postoperative bleeding complications (P=0.01). When the type of hernia, age, smoking, diabetes, and body mass index were included in a multivariate analysis, statins remained borderline significant as an independent predictor of wound hematoma/postoperative bleeding (P=0.04), odds ratio 1.6 (95% CI 1.03–2.44). Patients who undergo inguinal herniorrhaphy while on statins have an increased risk of postoperative wound hematoma/hemorrhage. Focus on additional factors that may affect the propensity to postoperative bleeding and on meticulous intraoperative hemostasis are particularly important in such patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM (2004) Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291:2092–2099
Liappis AP, Kan VL, Rochester CG, Simon GL (2001) The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33:1352–1357
Taylor EW, Duffy K, Lee K, Hill R, Noone A, Macintyre I, King PM, O’Dwyer PJ (2003) Surgical site infection after groin hernia repair. Br J Surg 91:105–111
Dunne JR, Malone DL, Tracy JK, Napolitano LM (2003) Abdominal wall hernias: risk factors for infection and resource utilization. J Surg Res 111:78–84
White TJ, Santos MC, Thompson JS (1998) Factors affecting wound complications in repair of ventral hernias. Am Surg 64:276–280
Medina M, Sillero M, Martinez-Gallego G, Delgado-Rodriguez M (1997) Risk factors of surgical wound infection in patients undergoing herniorrhaphy. Eur J Surg 163:191–198
Wang J, Mehta JL, Fink LM, Hauer-Jensen M (2004) Anticoagulant effects of statins. In: Mehta JL (ed) Statins—understanding clinical use. Saunders, Philadelphia, pp 233–256
Kwak B, Mulhaupt F, Myit S, Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6:1399–1402
Park HJ, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper JB (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91:143–150
Eto M, Kozai T, Cosentino F, Joch H, Luscher TF (2002) Statin prevents tissue factor expression in human endothelial cells. Role of Rho/Rho-kinase and Akt pathways. Circulation 105:1756–1759
Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D, Mehta JL, Ponnappan U, Lin P, Fink LM, Hauer-Jensen M (2003) Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis 14:575–585
Wiesbauer F, Kaun C, Zorn G, Maurer G, Huber K, Wojta J (2002) HMG CoA reductase inihibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins. Br J Pharmacol 135:284–292
Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A (2001) Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 161:1405–1410
Thompson PD, Moyna NM, White CM, Weber KM, Giri S, Waters DD (2002) The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation. Atherosclerosis 161:301–306
Dommering M (1979) Low-dose heparin prophylaxis in herniorrhaphy? A prospective trial in bleeding complications. Arch Chir Neerl 31:57–61
Schmitz R, Kansy M, Moser KH, Treckmann J (1996) Effect of low-dose subcutaneous heparin on postoperative wound hematomas: randomized clinical trial on hospitalized inguinal hernia patients in Germany. World J Surg 19:416–419
Canonico S, Sciaudone G, Pacifico F, Santoriello A (1999) Inguinal hernia repair in patients with coagulation problems: prevention of postoperative bleeding with human fibrin glue. Surgery 125:315–317
Acknowledgement
These data were presented in part at Hernia Repair 2005, the annual conference of the American Hernia Society, February 9–12, 2005, in San Diego, California.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hauer-Jensen, M., Fort, C., Mehta, J.L. et al. Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia 10, 48–52 (2006). https://doi.org/10.1007/s10029-005-0030-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10029-005-0030-x